<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04145830</url>
  </required_header>
  <id_info>
    <org_study_id>CS18-CHN-04</org_study_id>
    <nct_id>NCT04145830</nct_id>
  </id_info>
  <brief_title>UCP Glaucoma Treatment for Primary Glaucoma in China</brief_title>
  <official_title>Efficacy and Safety of UCP in the Treatment of Primary Glaucoma in China</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>EyeTechCare</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>EyeTechCare</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To collect safety and efficacy data on Ultrasound Cycle Plasty treatment (UCP) in primary
      glaucoma asian patients.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy endpoint : reduction of the intraocular pressure</measure>
    <time_frame>6 months</time_frame>
    <description>Reduction of the intraocular pressure relative to the preoperative value at each follow-up visits in mmHg and in % of reduction</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Safety endpoint: rate of per operative complications</measure>
    <time_frame>6 months</time_frame>
    <description>Rate of per-operative device and/or procedure related adverse events</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety endpoint: rate of post-operative complications</measure>
    <time_frame>6 months</time_frame>
    <description>Rate of post-operative complications during the follow-up period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Efficacy endpoint: Number of ocular hypotensive medications</measure>
    <time_frame>6 months</time_frame>
    <description>Mean number of IOP lowering medications at each visit during the follow-up period</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Glaucoma Treatment Using Focused Ultrasound</condition>
  <arm_group>
    <arm_group_label>Ultrasound Cyclo Plasty (UCP)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ultrasound Cyclo Plasty (UCP) using focused ultrasound</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ultrasound Cyclo Plasty (UCP)</intervention_name>
    <description>Cyclocoagulation using High Intensity Focused Ultrasound</description>
    <arm_group_label>Ultrasound Cyclo Plasty (UCP)</arm_group_label>
    <other_name>UCP by EyeOP1 device</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Primary Open Angle and primary Angle Closure glaucoma

          -  Subject where the IOP is not adequately controlled with glaucoma medication, and can
             not or not agree for incisional glaucoma surgery

          -  IOP ≥ 21 mmHg and ≤ 40 mmHg

          -  Best Corrected Visual Acuity &gt; Hand Motion

          -  Patient able and willing to sign the informed consent and complete postoperative
             followup requirements

        Exclusion Criteria:

          -  History of ocular or retrobulbar tumor

          -  Ocular infection within 14 days prior to the procedure of Ultrasound Cyclo Plasty
             (UCP)

          -  History of Cyclo-destructive procedures (cryotherapy, Laser transscleral
             cyclophotocoagulation; Laser endophotocoagulation)

          -  Congenital glaucoma

          -  History of ciliary body surgery or vitrectomy in the study eye

          -  Ocular disease other than glaucoma that may affect assessment of visual acuity and/or
             IOP (choroidal hemorrhage or detachment, lens subluxation, thyroid ophthalmopathy,
             proliferative diabetic retinopathy, clinical significant macular edema, retinal
             detachment)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Shanghai Eye Diseases Prevention and Treatment Center - Department of Ophthalmology</name>
      <address>
        <city>Shanghai</city>
        <zip>2000040</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ling Ge, MD</last_name>
      <phone>+86-21-62717733</phone>
      <phone_ext>851</phone_ext>
      <email>geling99@sina.com</email>
    </contact>
    <investigator>
      <last_name>Ling Ge, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>E&amp;ENT Fudan University</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Junyi Chen, Prof.</last_name>
      <email>chenjy@fudan.edu.cn</email>
    </contact>
    <investigator>
      <last_name>Junyi Chen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Aptel F, Denis P, Rouland JF, Renard JP, Bron A. Multicenter clinical trial of high-intensity focused ultrasound treatment in glaucoma patients without previous filtering surgery. Acta Ophthalmol. 2016 Aug;94(5):e268-77. doi: 10.1111/aos.12913. Epub 2015 Nov 7.</citation>
    <PMID>26547890</PMID>
  </reference>
  <reference>
    <citation>Torky MA, Al Zafiri YA, Hagras SM, Khattab AM, Bassiouny RM, Mokbel TH. Safety and efficacy of ultrasound ciliary plasty as a primary intervention in glaucoma patients. Int J Ophthalmol. 2019 Apr 18;12(4):597-602. doi: 10.18240/ijo.2019.04.12. eCollection 2019.</citation>
    <PMID>31024813</PMID>
  </reference>
  <reference>
    <citation>De Gregorio A, Pedrotti E, Stevan G, Montali M, Morselli S. Safety and efficacy of multiple cyclocoagulation of ciliary bodies by high-intensity focused ultrasound in patients with glaucoma. Graefes Arch Clin Exp Ophthalmol. 2017 Dec;255(12):2429-2435. doi: 10.1007/s00417-017-3817-4. Epub 2017 Oct 17.</citation>
    <PMID>29043438</PMID>
  </reference>
  <reference>
    <citation>Posarelli C, Covello G, Bendinelli A, Fogagnolo P, Nardi M, Figus M. High-intensity focused ultrasound procedure: The rise of a new noninvasive glaucoma procedure and its possible future applications. Surv Ophthalmol. 2019 Nov - Dec;64(6):826-834. doi: 10.1016/j.survophthal.2019.05.001. Epub 2019 May 22. Review.</citation>
    <PMID>31125570</PMID>
  </reference>
  <reference>
    <citation>Giannaccare G, Vagge A, Sebastiani S, Urbini LE, Corazza P, Pellegrini M, Carmassi L, Bergamini F, Traverso CE, Campos EC. Ultrasound Cyclo-Plasty in Patients with Glaucoma: 1-Year Results from a Multicentre Prospective Study. Ophthalmic Res. 2019;61(3):137-142. doi: 10.1159/000487953. Epub 2018 May 16.</citation>
    <PMID>29768281</PMID>
  </reference>
  <reference>
    <citation>Pellegrini M, Sebastiani S, Giannaccare G, Campos EC. Intraocular inflammation after Ultrasound Cyclo Plasty for the treatment of glaucoma. Int J Ophthalmol. 2019 Feb 18;12(2):338-341. doi: 10.18240/ijo.2019.02.23. eCollection 2019.</citation>
    <PMID>30809493</PMID>
  </reference>
  <reference>
    <citation>Melamed S, Goldenfeld M, Cotlear D, Skaat A, Moroz I. High-intensity focused ultrasound treatment in refractory glaucoma patients: results at 1 year of prospective clinical study. Eur J Ophthalmol. 2015 Nov-Dec;25(6):483-9. doi: 10.5301/ejo.5000620. Epub 2015 May 13.</citation>
    <PMID>25982212</PMID>
  </reference>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>October 29, 2019</study_first_submitted>
  <study_first_submitted_qc>October 29, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 31, 2019</study_first_posted>
  <last_update_submitted>October 31, 2019</last_update_submitted>
  <last_update_submitted_qc>October 31, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 4, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Glaucoma, ciliary body, ultrasound</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

